184 related articles for article (PubMed ID: 1699471)
1. Galanin immunoreactivity is increased in the nucleus basalis of Meynert in Alzheimer's disease.
Beal MF; MacGarvey U; Swartz KJ
Ann Neurol; 1990 Aug; 28(2):157-61. PubMed ID: 1699471
[TBL] [Abstract][Full Text] [Related]
2. Monoaminergic and cholinergic synaptic markers in the nucleus basalis of Meynert (nbM): normal age-related changes and the effect of heart disease and Alzheimer's disease.
Sparks DL; Hunsaker JC; Slevin JT; DeKosky ST; Kryscio RJ; Markesbery WR
Ann Neurol; 1992 Jun; 31(6):611-20. PubMed ID: 1355334
[TBL] [Abstract][Full Text] [Related]
3. Galanin hyperinnervates surviving neurons of the human basal nucleus of Meynert in dementias of Alzheimer's and Parkinson's disease: a hypothesis for the role of galanin in accentuating cholinergic dysfunction in dementia.
Chan-Palay V
J Comp Neurol; 1988 Jul; 273(4):543-57. PubMed ID: 2463283
[TBL] [Abstract][Full Text] [Related]
4. Preservation of nucleus basalis neurons containing choline acetyltransferase and the vesicular acetylcholine transporter in the elderly with mild cognitive impairment and early Alzheimer's disease.
Gilmor ML; Erickson JD; Varoqui H; Hersh LB; Bennett DA; Cochran EJ; Mufson EJ; Levey AI
J Comp Neurol; 1999 Sep; 411(4):693-704. PubMed ID: 10421878
[TBL] [Abstract][Full Text] [Related]
5. m2 muscarinic acetylcholine receptor-immunoreactive neurons are not reduced within the nucleus basalis in Alzheimer's disease: relationship with cholinergic and galaninergic perikarya.
Mufson EJ; Jaffar S; Levey AI
J Comp Neurol; 1998 Mar; 392(3):313-29. PubMed ID: 9511920
[TBL] [Abstract][Full Text] [Related]
6. The neurochemistry of Alzheimer's disease.
Engelborghs S; De Deyn PP
Acta Neurol Belg; 1997 Jun; 97(2):67-84. PubMed ID: 9246374
[TBL] [Abstract][Full Text] [Related]
7. [Neuromodulators and Alzheimer's disease].
Vallet PG; Bouras C
Encephale; 1988; 14(5):345-51. PubMed ID: 2463900
[TBL] [Abstract][Full Text] [Related]
8. Galanin-like immunoreactivity is unchanged in Alzheimer's disease and Parkinson's disease dementia cerebral cortex.
Beal MF; Clevens RA; Chattha GK; MacGarvey UM; Mazurek MF; Gabriel SM
J Neurochem; 1988 Dec; 51(6):1935-41. PubMed ID: 2460590
[TBL] [Abstract][Full Text] [Related]
9. Clinical and neurochemical consequences of neuronal loss in the nucleus basalis of Meynert in Parkinson's disease and Alzheimer's disease.
Whitehouse PJ
Adv Neurol; 1987; 45():393-7. PubMed ID: 2881448
[No Abstract] [Full Text] [Related]
10. Measurement of basal forebrain atrophy in Alzheimer's disease using MRI.
Teipel SJ; Flatz WH; Heinsen H; Bokde AL; Schoenberg SO; Stöckel S; Dietrich O; Reiser MF; Möller HJ; Hampel H
Brain; 2005 Nov; 128(Pt 11):2626-44. PubMed ID: 16014654
[TBL] [Abstract][Full Text] [Related]
11. [Abnormalities of neurotransmitters in Alzheimer's disease. Disturbance of the acetylcholine system and nucleus basalis of Meynert].
Arai H; Iizuka R
Nihon Rinsho; 1988 Jul; 46(7):1491-5. PubMed ID: 3221455
[No Abstract] [Full Text] [Related]
12. Galanin mRNA in the nucleus basalis of Meynert complex of baboons and humans.
Walker LC; Rance NE; Price DL; Young WS
J Comp Neurol; 1991 Jan; 303(1):113-20. PubMed ID: 1706362
[TBL] [Abstract][Full Text] [Related]
13. Neurotransmitter changes in Alzheimer's disease: implications to diagnostics and therapy.
Reinikainen KJ; Soininen H; Riekkinen PJ
J Neurosci Res; 1990 Dec; 27(4):576-86. PubMed ID: 1981917
[TBL] [Abstract][Full Text] [Related]
14. Decreased TrkA gene expression in cholinergic neurons of the striatum and basal forebrain of patients with Alzheimer's disease.
Boissiere F; Faucheux B; Ruberg M; Agid Y; Hirsch EC
Exp Neurol; 1997 May; 145(1):245-52. PubMed ID: 9184126
[TBL] [Abstract][Full Text] [Related]
15. Peptidergic neurons in the basal forebrain magnocellular complex of the rhesus monkey.
Walker LC; Koliatsos VE; Kitt CA; Richardson RT; Rökaeus A; Price DL
J Comp Neurol; 1989 Feb; 280(2):272-82. PubMed ID: 2466877
[TBL] [Abstract][Full Text] [Related]
16. Apoptotic signals within the basal forebrain cholinergic neurons in Alzheimer's disease.
Wu CK; Thal L; Pizzo D; Hansen L; Masliah E; Geula C
Exp Neurol; 2005 Oct; 195(2):484-96. PubMed ID: 16085017
[TBL] [Abstract][Full Text] [Related]
17. Hyperinnervation of surviving neurons of the human basal nucleus of meynert by galanin in dementias of Alzheimer's and Parkinson's disease.
Chan-Palay V
Adv Neurol; 1990; 51():253-5. PubMed ID: 1688477
[No Abstract] [Full Text] [Related]
18. Galanin-like immunoreactivity is present in human substantia innominata and in senile plaques in Alzheimer's disease.
Kowall NW; Beal MF
Neurosci Lett; 1989 Mar; 98(1):118-23. PubMed ID: 2469045
[TBL] [Abstract][Full Text] [Related]
19. [Neuropathology of Alzheimer's disease and mild cognitive impairment].
López OL; DeKosky ST
Rev Neurol; 2003 Jul 16-31; 37(2):155-63. PubMed ID: 12938076
[TBL] [Abstract][Full Text] [Related]
20. Alzheimer's disease: monoamines and spiperone binding reduced in nucleus basalis.
Sparks DL; Markesbery WR; Slevin JT
Ann Neurol; 1986 Jun; 19(6):602-4. PubMed ID: 2425718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
